Raymond James upgraded shares of Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Free Report) to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports.
Separately, Alliance Global Partners upgraded Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a report on Thursday, September 26th.
Get Our Latest Report on Invesco S&P Emerging Markets Low Volatility Index ETF
Invesco S&P Emerging Markets Low Volatility Index ETF Price Performance
About Invesco S&P Emerging Markets Low Volatility Index ETF
Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Featured Stories
- Five stocks we like better than Invesco S&P Emerging Markets Low Volatility Index ETF
- When to Sell a Stock for Profit or Loss
- Abbott Laboratories Will Outperform Healthcare Stocks in 2025
- How to Use the MarketBeat Excel Dividend Calculator
- PepsiCo: 53 Years of Dividend Growth and Still Going Strong
- What is the Euro STOXX 50 Index?
- Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
Receive News & Ratings for Invesco S&P Emerging Markets Low Volatility Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco S&P Emerging Markets Low Volatility Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
